⚕ GalenOps CRO console
← 718 (USA)

718-1170

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 718 (USA) (Dr. Nolan) · consented 2013-09-16
Adverse events
6
Serious AEs
1
Open data queries
0
Luna dropout signal
–

Adverse events

severe assessed 2026-08-18

Severe AGITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-16 (study day 31.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild BODY TEMPERATURE INCREASED — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 26.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-10-07 (study day 22.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 26.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild HYPERTENSION — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 26.0); relationship: POSSIBLE

severe serious reported 2026-08-18

Severe SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-10-12 (study day 27.0); relationship: PROBABLE; serious criteria: hospitalization

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.